Niels Abildgaard

  • Clinical professor, Chief Physician, DMSc, Head of research Unit, KI, Haematology
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Activities

Filter
Talks and presentations in private or public companies

Role of ImiDs in Multiple Myeloma

Niels Abildgaard (Guest lecturer)
7. Feb 2018

Activity: Talks and presentationsTalks and presentations in private or public companies

Forsøgsbehandlinger ved myelomatose i Danmark

Niels Abildgaard (Guest lecturer)
7. Feb 2017

Activity: Talks and presentationsTalks and presentations in private or public companies

Health-Related Quality of Life (HRQoL) Measurements in Multiple Myeloma Patients Obtained By EORTC QLQ-C30; A Critical Review of Interpreting HRQoL Data in Longitudinal Studies

Lene Kongsgaard Nielsen (Lecturer), Mary Ellen Jarden (Other), Christen Lykkegaard Andersen (Other), Henrik Frederiksen (Other), Niels Abildgaard (Other)
3. Dec 20166. Dec 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

Health-Related Quality of Life (HRQoL) Measurements in Multiple Myeloma Patients Obtained By EORTC QLQ-C30; A Critical Review of Interpreting HRQoL Data in Longitudinal Studies

Lene Kongsgaard Nielsen (Lecturer), Mary Ellen Jarden (Other), Christen Lykkegaard Andersen (Other), Henrik Frederiksen (Other), Niels Abildgaard (Other)
3. Dec 20166. Dec 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

Mayloidose Center: Hvad er AL amyloidose, og hvordan håndteres dette?

Niels Abildgaard (Lecturer)
24. Nov 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

Behandlingsprotokoller i Danmark

Niels Abildgaard (Lecturer)
27. Oct 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

FDG-PET/CT in Multiple Myeloma

Niels Abildgaard (Lecturer)
11. Apr 201613. Apr 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

State-of-the Art – Behandling af myelomatose

Niels Abildgaard (Lecturer)
18. Mar 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

The new landscape in Multiple Myeloma

Niels Abildgaard (Lecturer)
18. Mar 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

Myelomatose - Behandling

Niels Abildgaard (Lecturer)
8. Jan 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

Myelomatose – Patogenese

Niels Abildgaard (Lecturer)
8. Jan 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

First-line treatment of HDT ineligible multiple myeloma patients

Niels Abildgaard (Lecturer)
12. Nov 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

The Danish Multiple Myeloma Registry demonstrates improved survival of multiple myeloma patients in Denmark

Niels Abildgaard (Lecturer)
28. Oct 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

DMSG 2005-2015 - highlights and achievements

Niels Abildgaard (Lecturer)
18. Sep 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

Limted duration therapy in Multiple Myeloma

Niels Abildgaard (Lecturer)
25. Feb 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

Myelomatose - sygdomslære og behandling

Niels Abildgaard (Lecturer)
19. Mar 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Bone marrow microenvironment in multiple myeloma

Niels Abildgaard (Lecturer)
4. Mar 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Multiple Myeloma Bone Disease

Niels Abildgaard (Lecturer)
28. Feb 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Multiple myeloma monitoring and indication for re-treatment

Niels Abildgaard (Lecturer)
31. Jan 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Dansk Hæmatologisk Selskabs Årsmøde for de Nationale Databaser. Årsrapport 2011, Myelomatose.

Niels Abildgaard (Lecturer)
22. Nov 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Treatment of Myeloma Bone Disease. European Haematology Association (EHA), 17th Meeting, EMN workshop, Amsterdam.

Niels Abildgaard (Lecturer)
14. Jun 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Myeloma Bone Disease. Nordisk Myelomatose Studie Gruppe (NMSG), Spring Meeting, Reykjavik.

Niels Abildgaard (Lecturer)
25. May 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Diagnostik og behandling af myelomatose - "State of the Art" i 2012. Dansk Hæmatologisk Selskabs 40. årsmøde, Hindsgavl.

Niels Abildgaard (Lecturer)
16. Mar 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

DMSG Educational Symposium

Niels Abildgaard (Other)
2011

Activity: Talks and presentationsTalks and presentations in private or public companies

International Myeloma Foundation/DMF meeting

Niels Abildgaard (Other)
2011

Activity: Talks and presentationsTalks and presentations in private or public companies

Behandlingsmæssige landvindinger i et historisk perspektiv. Onkologisk Staff Meeting, OUH, DK.

Niels Abildgaard (Lecturer)
5. May 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Primær behandling af yngre patienter med myelomatose. Celgene Symposium, København.

Niels Abildgaard (Lecturer)
20. Jan 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Bisfosfonatbehandling ved myelomatose, Dansk Tandlægeforening, Århus.

Niels Abildgaard (Lecturer)
6. Nov 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

Myelomatose. Hvad er det og hvad er den bedste behandling i dag og i morgen. Konference for Dansk Myelomatose Forening, Fredericia, DK.

Niels Abildgaard (Lecturer)
21. Mar 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

Bone imaging in multiple myeloma, Janssen-Cilag, Oslo.

Niels Abildgaard (Lecturer)
3. Feb 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

Knoglesygdommen ved myelomatose: Patofysiologiske aspekter og nye behandlingsmuligheder. Onkologisk-Hæmatologisk Regionsmøde, Odense, DK.

Niels Abildgaard (Lecturer)
8. Oct 2008

Activity: Talks and presentationsTalks and presentations in private or public companies

Myeloma bone disease; pathophysiology and new therapeutics. Celgene, København, DK.

Niels Abildgaard (Lecturer)
10. Sep 2008

Activity: Talks and presentationsTalks and presentations in private or public companies

New therapies in multiple myeloma. Celgene, København, DK.

Niels Abildgaard (Lecturer)
10. Sep 2008

Activity: Talks and presentationsTalks and presentations in private or public companies

Chairman ved posterpræsentation "Multiple Myeloma: Biology".  The 13th. European Haematology Association Congress, København, DK.

Niels Abildgaard (Lecturer)
12. Jun 2008

Activity: Talks and presentationsTalks and presentations in private or public companies

Bisfosfonatinduceret osteonekrose af kæben. Regionsmøde for Region Syddanmark, Odense, DK.

Niels Abildgaard (Lecturer)
10. Oct 2007

Activity: Talks and presentationsTalks and presentations in private or public companies

Behandling af myelomatose i år 2007. Dansk Myelomatose Forening, Fredericia, DK.

Niels Abildgaard (Lecturer)
30. Mar 2007

Activity: Talks and presentationsTalks and presentations in private or public companies

Nye terapeutika ved myelomatose. Dansk Hæmatologisk Selskabs årsmøde, Middelfart, DK.

Niels Abildgaard (Lecturer)
16. Mar 2007

Activity: Talks and presentationsTalks and presentations in private or public companies